(Press-News.org) SALT LAKE CITY, June 12, 2013 – Using hands-free devices to talk, text or send e-mail while driving is distracting and risky, contrary to what many people believe, says a new University of Utah study issued today by the AAA Foundation for Traffic Safety.
"Our research shows that hands-free is not risk-free," says University of Utah psychology Professor David Strayer, lead author of the study, which he conducted for the foundation arm of the nonprofit AAA, formerly known as the American Automobile Association.
"These new, speech-based technologies in the car can overload the driver's attention and impair their ability to drive safely," says Strayer. "An unintended consequence of trying to make driving safer – by moving to speech-to-text, in-vehicle systems – may actually overload the driver and make them less safe."
"Just because you can update Facebook while driving doesn't mean that it is safe to do so," he adds. "Don't assume that if your eyes are on the road and your hands are on the wheel that you are unimpaired. If you don't pay attention then you are a potential hazard on the roadway."
In a 2006 study, Strayer first showed talking on a hands-free cell phone was just as distracting as using a hand-held phone while driving, but the message has failed to fully connect with the public, with many people believing hands-free devices are safer. But now, with the backing of the AAA, Strayer hopes people realize they are risking their lives and those of others by using distracting hands-free phone, e-mailing, texting and social media technologies while driving.
Strayer conducted the study with these other members of the University of Utah Department of Psychology: Joel M. Cooper, research assistant professor of psychology; and doctoral students Jonna Turrill, James Coleman and Nate Medeiros-Ward and Francesco Biondi. Below is the AAA news release.
AAA FOUNDATION FOR TRAFFIC SAFETY
Think you know all about distracted driving? Think again, says AAA
New research reveals that voice-activated in-car technologies dangerously undermine driver attention
WASHINGTON, June 12, 2013 – Hands-free technologies might make it easier for motorists to text, talk on the phone, or even use Facebook while they drive, but new findings from the AAA Foundation for Traffic Safety show dangerous mental distractions exist even when drivers keep their hands on the wheel and their eyes on the road.
The research found that as mental workload and distractions increase, reaction time slows, brain function is compromised, drivers scan the road less and miss visual cues, potentially resulting in drivers not seeing items right in front of them including stop signs and pedestrians.
This is the most comprehensive study of its kind to look at the mental distraction of drivers and arms AAA with evidence to appeal to the public to not use these voice-to-text features while their vehicle is in motion.
With a predicted five-fold increase in infotainment systems in new vehicles by 2018, AAA is calling for action as result of this landmark research.
"There is a looming public safety crisis ahead with the future proliferation of these in-vehicle technologies," said AAA President and CEO Robert L. Darbelnet. "It's time to consider limiting new and potentially dangerous mental distractions built into cars, particularly with the common public misperception that hands-free means risk-free."
Cognitive distraction expert David Strayer and his research team at the University of Utah measured brainwaves, eye movement and other metrics to assess what happens to drivers' mental workload when they attempt to do multiple things at once, building upon decades of research in the aerospace and automotive industries. The research included:
Cameras mounted inside an instrumented car to track eye and head movement of drivers.
A Detection-Response-Task device known as the "DRT" was used to record driver reaction time in response to triggers of red and green lights added to their field of vision.
A special electroencephalographic (EEG)-configured skull cap was used to chart participants' brain activity so that researchers could determine mental workload.
Using established research protocols borrowed from aviation psychology and a variety of performance metrics, drivers engaged in common tasks, from listening to an audio book or talking on the phone to listening and responding to voice-activated emails while behind the wheel.
Researchers used the results to rate the levels of mental distraction drivers experienced while performing each of the tasks. Similar to the Saffir-Simpson scale used for hurricanes, the levels of mental distraction are represented on a scale:
Tasks such as listening to the radio ranked as a category "1" level of distraction or a minimal risk.
Talking on a cell-phone, both handheld and hands-free, resulted in a "2" or a moderate risk.
Listening and responding to in-vehicle, voice-activated email features increased mental workload and distraction levels of the drivers to a "3" rating or one of extensive risk.
"These findings reinforce previous research that hands-free is not risk-free," said AAA Foundation President and CEO Peter Kissinger. "Increased mental workload and cognitive distractions can lead to a type of tunnel vision or inattention blindness where motorists don't see potential hazards right in front of them."
Based on this research, AAA urges the automotive and electronics industries to join us in exploring:
Limiting use of voice-activated technology to core driving-related activities such as climate control, windshield wipers and cruise control, and to ensure these applications do not lead to increased safety risk due to mental distraction while the car is moving.
Disabling certain functionalities of voice-to-text technologies such as using social media or interacting with e-mail and text messages so that they are inoperable while the vehicle is in motion.
Educating vehicle owners and mobile device users about the responsible use and safety risks for in-vehicle technologies.
AAA also is using the findings to promote dialogue with policy makers, safety advocates and industry to ensure that these emerging in-vehicle technologies won't lead to unintentional compromises in public safety. As part of this effort, AAA has already met with safety advocates and provided copies of the report to CEOs of all major U.S. automakers.
"This study constitutes the most in-depth analysis to date of mental distractions behind the wheel. AAA is hopeful that it will serve as a stepping stone toward working in collaboration with automakers to promote our shared goal of improving safety for all drivers," said Darbelnet. "Specifically, these increasingly common voice-driven, in-vehicle technologies should be limited to use for just core driving tasks unless the activity results in no significant driver distraction."
INFORMATION:
To view the full Cognitive Distraction in the Vehicle report, the AAA Foundation's Research Compendium on Cognitive Distraction or AAA's Distracted Driving Fact Sheet, visit NewsRoom.AAA.com
Established by AAA in 1947, the AAA Foundation for Traffic Safety is a 501(c) (3) not-for-profit, publicly-supported charitable educational and research organization. Dedicated to saving lives and reducing injuries on our roads, the foundation's mission is to prevent crashes and save lives through research and education about traffic safety. The foundation has funded over 200 research projects designed to discover the causes of traffic crashes, prevent them, and minimize injuries when they do occur. Visit http://www.aaafoundation.org for more information on this and other research.
As North America's largest motoring and leisure travel organization, AAA provides more than 53 million members with travel, insurance, financial and automotive-related services. Since its founding in 1902, the not-for-profit, fully tax-paying AAA has been a leader and advocate for the safety and security of all travelers. AAA clubs can be visited on the Internet at AAA.com.
University of Utah Communications
75 Fort Douglas Boulevard
Salt Lake City, UT 84113
801-581-6773 fax: 801-585-3350
http://www.unews.utah.edu
Hands-free talking and texting are unsafe
University of Utah study for AAA warns of looming safety crisis
2013-06-12
ELSE PRESS RELEASES FROM THIS DATE:
Heroin availability increasing across Washington state
2013-06-12
New data from the University of Washington's Alcohol and Drug Abuse Institute indicates increases in heroin availability, abuse and deaths across the state, particularly among young adults ages 18-29. These increases are concerning because of the high risks of overdose and contracting infectious diseases associated with heroin use.
Police drug evidence testing, particularly in 2011 and 2012, points to dramatic increases in heroin. The largest increases were outside of metropolitan areas; the number of pieces of police evidence positive for heroin totaled 842 in 2007 and ...
EULAR 2013 highlights
2013-06-12
Madrid, Spain, 12 June 2013: The launch of the European Rheumatology Research Foundation (ERRF) was today announced at EULAR 2013, the Annual Congress of the European League Against Rheumatism.
The European Rheumatology Research Foundation (ERRF) is an independent, non-profit body devoted to promoting research in rheumatic and musculoskeletal diseases (RMDs). The ERRF supports high-quality, peer-reviewed research by raising funds from commercial and non-commercial donors. The ERRF aims to support basic and applied research in order to reduce the burden of disease for ...
Significant improvements in psoriatic arthritis with ustekinumab
2013-06-12
Madrid, Spain, 12 June 2013: New PSUMMIT 2* data first presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, further demonstrate the efficacy of ustekinumab in Psoriatic Arthritis (PsA).
Anti-TNF naïve and anti-TNF-experienced patients randomised to one of two ustekinumab doses (45mg or 90mg) demonstrated significant and sustained improvements in the signs and symptoms of PsA, with favourable safety profiles.
PsA is a chronic inflammatory arthritis associated with psoriasis which significantly impacts health-related quality of life ...
Patients use OTC NSAIDs even when they have a high risk of serious side effects
2013-06-12
Madrid, Spain, 12 June 2013: A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, shows that one in eight patients at risk of developing a serious adverse drug event (ADE) is taking over-the-counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs), often to treat a musculoskeletal complaint.
Of these high risk OTC NSAID users, over one-third had taken the medication for more than 7 days, and 3% had exceeded the maximum recommended daily dosage.
Patients were considered at high risk of a serious ADE from OTC ...
Brodalumab demonstrates significant clinical response in psoriatic arthritis
2013-06-12
Madrid, Spain, 12 June 2013: A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, shows that treatment with brodalumab demonstrates significant clinical response and an acceptable safety profile in subjects with psoriatic arthritis (PsA).
PsA is a chronic inflammatory arthritis associated with psoriasis which significantly impacts health-related quality of life in patients, and increases risk of co-morbid cardiovascular and gastrointestinal diseases.2 Psoriasis occurs in 2-3% of the population, with PsA occurring in ...
'Fast track' approach to giant cell arteritis significantly reduces risk of blindness
2013-06-12
Madrid, Spain, 12 June 2013: A new study presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, shows that rapid evaluation for Giant Cell Arteritis (GCA) by Color Doppler Ultrasound (CDUS) followed by immediate initiation of treatment (if required) significantly reduces permanent vision loss.
Of the patients evaluated by the ''fast track'' principle from March 2010 to December 2012, 11.1% had transient visual manifestations, and none went on to suffer from permanent visual loss.
GCA is a condition in which medium and large-size arteries, ...
CHERISH trial demonstrates efficacy of tocilizumab in juvenile idiopathic arthritis
2013-06-12
Madrid, Spain, 12 June 2013: A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism shows that tocilizumab is efficacious and leads to a sustained clinically meaningful improvement in children with polyarticular Juvenile Idiopathic Arthritis (pcJIA).
Tocilizumab is a humanized recombinant antibody, which blocks the receptors where interleukin-6 (IL-6) attaches to the surface of cells. When IL-6 is unable to attach to these cells, they are prevented from driving inflammation. Elevated serum and joint fluid IL-6 levels ...
Abatacept as effective as adalimumab in rheumatoid arthritis
2013-06-12
Madrid, Spain, 12 June 2013: Data from AMPLE presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate comparable efficacy and similar safety profiles between subcutaneous abatacept (ABA) and adalimumab (ADA).
AMPLE, the first two-year head-to-head biologics trial, was comprised of 646 biologic-naïve patients with active rheumatoid arthritis (RA) equally randomised to either ABA or ADA, with a stable dose of methotrexate (MTX). 79.2% (252 of 318) ABA patients and 74.7% (245 of 328) ADA patients completed the trial.
RA is a ...
Long-term apremilast demonstrates continued efficacy in patients with psoriatic arthritis
2013-06-12
Madrid, Spain, 12 June 2013: New data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism show that apremilast administered to patients with psoriatic arthritis continues to demonstrate meaningful clinical responses beyond 24 weeks. For patients who completed 52 weeks of the study, up to 65% achieved ACR20* response rates. Also, apremilast continued to be well tolerated with an acceptable longer-term safety profile.
Apremilast is a novel, oral small-molecule inhibitor of phosphodiesterase 4 (PDE4). It works as an anti-inflammatory ...
New method successfully scores joint damage in rheumatoid arthritis
2013-06-12
Madrid, Spain, 12 June 2013: A new study presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrates the efficacy of the ARASHI method at evaluating radiographic (X-ray) joint damage in RA.
The study validated the use of ARASHI to assess joint damage in RA, and clarified the pattern of progression of damage during two-year TNF-blocking therapies. In addition to concluding the success of the scoring method, the data also showed that hip and knee joints with pre-existing damage were predisposed to continue destruction, even during ...
LAST 30 PRESS RELEASES:
Does the neuron know the electrode is there?
Vilcek Foundation celebrates immigrant scientists with $250,000 in prizes
Age and sex differences in efficacy of treatments for type 2 diabetes
Octopuses have some of the oldest known sex chromosomes
High-yield rice breed emits up to 70% less methane
Long COVID prevalence and associated activity limitation in US children
Intersection of race and rurality with health care–associated infections and subsequent outcomes
Risk of attempted and completed suicide in persons diagnosed with headache
Adolescent smartphone use during school hours
Alarming rise in rates of advanced prostate cancer in California
Nearly half of adults mistakenly think benefits of daily aspirin outweigh risks
Cardiovascular disease medications underused globally
Amazon Pharmacy's RxPass program improves medication adherence, helps prime members save money, study finds
Tufts University School of Medicine, ATI Physical Therapy launch first-of-its-kind collaboration to make physical therapy education and career advancement more accessible and affordable
Could lycopene—a plant extract—be an effective antidepressant?
Study shows urine test for prostate cancer could be used at home
Shaping future of displays: clay/europium-based technology offers dual-mode versatility
Optimizing ADHD treatment: revealing key components of cognitive–behavioral therapy
Breaking barriers in thioxanthone synthesis: a double aryne insertion strategy
Houston Methodist researchers identify inhibitor drugs to treat aggressive breast cancer
Skin disease patients show response to targeted treatment
Tiny copper ‘flowers’ bloom on artificial leaves for clean fuel production
Cracks in Greenland Ice Sheet grow more rapidly in response to climate change
Computer model helps identify cancer-fighting immune cells key to immunotherapy
Keeper or corner?
Printable molecule-selective nanoparticles enable mass production of wearable biosensors
Mapping the yerba mate genome reveals surprising facts about the evolution of caffeine
Electricity prices across Europe to stabilise if 2030 targets for renewable energy are met, study suggests
Improved treatment timing reduces honey bee losses to Varroa mites
CAR-T cells can arm bystander T cells with CAR molecules via trogocytosis
[Press-News.org] Hands-free talking and texting are unsafeUniversity of Utah study for AAA warns of looming safety crisis